1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Lung Carcinoma: new trials by email Literature Review of Lung Carcinoma trials Research Report on Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma Apatinib - Lung Carcinoma | Phase 2 | Unknown | Guangzhou Institute of Respiratory Disease | 33 | 2018-10-19 | 2018-10-24 |
Lung Neoplasms (1)
Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
apatinib (1)
Guangzhou Institute of Respiratory Disease (1)
China (1)